Tianjin Zhong Xin Pharmaceutical Group Corp. Ltd. financial statements, including revenue, expenses, profit, and loss
The total revenue of 2TZ for the last quarter is 265.98 M EUR, and it's 11.70% lower compared to the previous quarter. The net income of Q1 24 is 49.94 M EUR.